According to a report from Tufts Center for the Study of Drug Development (CSDD), clinical trials using adaptive designs, which currently account for about 20 percent of trials, are on the rise. Read More
Scripps Research Institute (TSRI) scientists have developed a powerful new technique for rapidly discovering antibodies that have a desired biological effect. Read More
